FDA 483 - Steris Laboratories - August 01, 2025

An FDA Form 483 was issued to STERIS Laboratories, Inc. in Brooklyn Park, MN, following an inspection that identified two significant observations. The firm's procedures for corrective and preventive actions were found to be inadequately established, failing to consistently initiate CAPAs based on risk analysis and data. Additionally, procedures for finished device acceptance were not adequately formalized or documented, specifically regarding post-processing visual inspections.